COMMUNIQUÉS West-GlobeNewswire

Cannara Completes Acquisition of Medican Organic Inc.
06/05/2026
MONTREAL, May 06, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, the “ Company ”, “ us ” or “ we ”) ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Hope Air Marks 40 Years of Changing Health Outcomes for Patients Needing to Travel Long Distances for Care
06/05/2026
Hope Air Day 2026 highlights the charity’s role in fulfilling Canada’s promise of universal healthcare TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- On May 6, Hope Air marks 40 years of helping Canadians who must travel [...]
Tekton Research Appoints Dr. Amit Vijapura as Central Nervous System Key Opinion Leader
06/05/2026
As CNS capabilities expand, Tekton adds seasoned leadership to accelerate growth and execution AUSTIN, Texas, May 06, 2026 (GLOBE NEWSWIRE) -- Tekton Research , a leading multi-site clinical trial organization with 25 [...]
Where Executives Are Doubling Down on Their Companies’ Fortunes
06/05/2026
4 Stocks Under $15 Seeing Aggressive Insider Buying Activity DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- 24/7 Market News and NeOnc Technology -- As market participants are sifting through data, one signal often cuts [...]
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
06/05/2026
Jena, Germany, May 06, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today the [...]
MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update
06/05/2026
CLEARWATER, Fla., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB:MWAI) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and [...]
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
06/05/2026
$15 million payment fulfills previously scheduled tranche under royalty-based financing agreement, bringing total capital received from Ligand to $40 million to date in exchange for tiered royalty interest in Orchestra [...]
Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform
06/05/2026
Transaction marks one of the first clinical-stage oncology acquisitions sourced, evaluated, and executed through an AI-powered drug development platform NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Pathos AI, a clinical- [...]
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
06/05/2026
MIAMI, FL, May 06, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
06/05/2026
MONTREAL and CHARLOTTE, May 06, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
06/05/2026
SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, [...]
Becoming Independent Celebrates Outstanding Individuals and Partners at Second Annual Spotlight Awards
06/05/2026
Charles M. Schulz Museum, Morton & Bassett Spices, Alsco Uniforms among those honored SANTA ROSA, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Becoming Independent , a nonprofit supporting adults with disabilities live [...]
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
06/05/2026
Conference Call and Webcast Scheduled for May 13, 2026 at 2 p.m. PT/5 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology [...]
Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101
06/05/2026
Final results confirm and build on interim BIRCH results in 23 ICH patients Primary safety endpoint met with no mortality observed Encouraging efficacy signals on all clinical and biomarker endpoints New adaptive [...]
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
06/05/2026
AGOURA HILLS, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a late-stage clinical biopharmaceutical company focused on oncology and rare [...]
Better Blend Continues Growth with Second Lexington Location
06/05/2026
Fast-growing Midwest brand brings low-sugar, high-protein menu to the area LEXINGTON, Ky., May 06, 2026 (GLOBE NEWSWIRE) -- Better Blend, a rapidly growing smoothie and bowl brand, opened its second location in [...]
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
06/05/2026
Reaffirmed FDA alignment on TSHA-102 BLA pathway, including pivotal trial design, endpoints and potential to submit for approval based on REVEAL pivotal trial 6-month interim analysis, following recent breakthrough [...]
Trading by management and close relations of management
06/05/2026
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the [...]
Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
06/05/2026
WARREN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives [...]

Pages